- Home
- WEAV vs SIGA Comparison
WEAV vs SIGA Comparison
Compare WEAV & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WEAV | SIGA |
|---|---|---|
| Founded | 2011 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 543.8M | 462.6M |
| IPO Year | 2021 | 1997 |
Fundamental Metrics
Financial Performance| Metric | WEAV | SIGA |
|---|---|---|
| Price | $7.17 | $6.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $12.20 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 334.4K |
| Earning Date | 02-19-2026 | 11-06-2025 |
| Dividend Yield | N/A | ★ 9.84% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $229,790,000.00 | $172,249,641.00 |
| Revenue This Year | $19.19 | N/A |
| Revenue Next Year | $15.09 | $132.36 |
| P/E Ratio | ★ N/A | $5.92 |
| Revenue Growth | ★ 17.34 | N/A |
| 52 Week Low | $5.64 | $4.95 |
| 52 Week High | $17.63 | $9.62 |
Technical Indicators
Market Signals| Indicator | WEAV | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 56.84 | 46.31 |
| Support Level | $6.96 | $6.08 |
| Resistance Level | $7.15 | $6.45 |
| Average True Range (ATR) | 0.31 | 0.15 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 50.48 | 40.22 |
Price Performance
Historical ComparisonAbout WEAV Weave Communications Inc.
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.